However, although IDO1 and its metabolites have been reported to directly promote the cell proliferation and tumorigenesis and inhibit apoptosis in colon cancer cells32–34, our current data could still not establish a direct causal link between the tumor regression and the reduced IDO1 expression following the treatment with BET inhibitors, which requires additional investigations. This evidence concerns the gene IDO1 and colonic neoplasm.